Difference between revisions of "Kahn M, et al. Nat. Rev. Drug Discov. (2014) cited as Ref 122 in DOI: 10.1038/s41392-020-0110-5 (Q9385)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: DOI Identifier (P138): 10.1038/nrd4233, #quickstatements; #temporary_batch_1590000649558)
(‎Created claim: Page(s) (P105): 513-532, #quickstatements; #temporary_batch_1590074839150)
 
(5 intermediate revisions by the same user not shown)
Property / PubMed ID
 +
Property / PubMed ID: 24981364 / rank
 +
Normal rank
Property / Publication Date
 +
2014
Timestamp+2014-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2014 / rank
 +
Normal rank
Property / Published In Name String
 +
Nat. Rev. Drug Discov.
Property / Published In Name String: Nat. Rev. Drug Discov. / rank
 +
Normal rank
Property / Volume
 +
13
Property / Volume: 13 / rank
 +
Normal rank
Property / title
 +
Can we safely target the WNT pathway? (English)
Property / title: Can we safely target the WNT pathway? (English) / rank
 +
Normal rank
Property / Page(s)
 +
513-532
Property / Page(s): 513-532 / rank
 +
Normal rank

Latest revision as of 15:31, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Kahn M, et al. Nat. Rev. Drug Discov. (2014) cited as Ref 122 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Kahn M
    0 references
    0 references
    2014
    0 references
    Nat. Rev. Drug Discov.
    0 references
    13
    0 references
    Can we safely target the WNT pathway? (English)
    0 references
    513-532
    0 references